Medicover revenue and financials

MCOV.B · Nasdaq Stockholm · SEK

kr 261.50Change from previous close: +0.58%Absolute change: +kr 1.50

Close · October 7, 2026

In the fiscal year ended December 2025, Medicover reported revenue of €2.38B (+13.69% year over year). Net income was €77.5M, a net margin of 3.3%.

Annual revenue · 2025: €2.38B
  1. €1.51B2022
  2. €1.75B2023
  3. €2.09B2024
  4. €2.38B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+13.69%
2025 vs 2024
Net income growth
+364.07%
2025 vs 2024
Net margin
3.3%
2024: 0.8%

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Balance sheet · Annual
Item20252024202320222021
Total assets2,4212,1381,9411,832—
Current assets497447381334—
Cash and equivalents82.369.850.840.4—
Short-term investments5.913.013.68.7—
Inventory67.269.159.458.2—
Net property, plant and equipment1,049976876841—
Goodwill655524517496—
Other intangible assets158133122126—
Long-term investments0.80.70.80.8—
Current liabilities708566501356—
Accounts payable11389.568.061.0—
Long-term debt621543406473—
Total debt1,4401,2391,004940—
Total liabilities1,8761,6491,4131,324—
Total equity (incl. minority)545489528509—
Retained earnings13273.5129125—
Minority interest12.124.531.836.1—